Last reviewed · How we verify
Standardized Propofol Administration
At a glance
| Generic name | Standardized Propofol Administration |
|---|---|
| Sponsor | Pontificia Universidad Catolica de Chile |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery (PHASE3)
- Intubation Conditions Achieved With Rapid Co-administration of Rocuronium and Propofol Versus Classical Induction (PHASE4)
- Targeted Hypothermia Versus Targeted Normothermia After Convulsive Refractory Status Epilepticus (PHASE3)
- Comparison of Prolotherapy and Rehabilitation Treatments in Low Back Pain (CPRTLBP) (NA)
- Effect of Nalbuphine on Hemodynamic Response During Laryngoscopy and Intubation (NA)
- Nalbuphine Timing Effects on Hemodynamics and Analgesia in Elderly Patients (PHASE4)
- DISE-HNS Effect Study (NA)
- Patient-controlled Sedation With Propofol Versus Anesthesiologist-administered Sedation for Orthopedic Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: